Anticholinergic activity in the nervous system: Consequences for visuomotor function
- 1 March 2017
- journal article
- review article
- Published by Elsevier in Physiology & Behavior
- Vol. 170, 6-11
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse, and Parkinson’s DiseaseACS Chemical Neuroscience, 2011
- Preclinical assessment of CNS drug action using eye movements in miceJournal of Clinical Investigation, 2011
- The cholinergic system and Parkinson diseaseBehavioural Brain Research, 2011
- Utility of saccadic eye movement analysis as an objective biomarker to detect the sedative interaction between opioids and sleep deprivation in opioid-naive and opioid-tolerant populationsJournal of Psychopharmacology, 2010
- Anticholinergic syndrome following an unintentional overdose of scopolamineTherapeutics and Clinical Risk Management, 2009
- Pharmacological treatment effects on eye movement controlBrain and Cognition, 2008
- Cholinergic Interneurons Are Differentially Distributed in the Human StriatumPLOS ONE, 2007
- Saccades and pursuit: two outcomes of a single sensorimotor processThe Journal of Physiology, 2007
- Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderBritish Journal of Pharmacology, 2006
- Functional analysis of muscarinic acetylcholine receptors using knockout miceLife Sciences, 2004